Dr Mitchell Glass discusses Invion’s pipeline

In this video recorded on 18 April 2013, Dr Mitchell Glass discusses Invion’s pipelines of two drug assets, currently in three phase II clinical programs – in asthma, chronic bronchitis and lupus.

Posted in Presentations